Identifying Rheumatoid Arthritis in the preclinical phase

Identifying Rheumatoid Arthritis in the preclinical phase - Identifying Rheumatoid Arthritis in the preclinical phase

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55369

Enrollment

1060

Registered

2012-02-08

Start date

2012-04-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory artralgia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Artralgia on hand or feet joints that is according to the rheumatologist clinical suspect to become RA (eg because of an inflammatory type or the presence of morning stiffness). • Recent onset of complaints (

Exclusion criteria

Exclusion criteria: • Arthritis at physical examination • Known other conditions that may explain the pain or interfere with the evaluation of pain severity (e.g. osteoarthritis, gout, fibromyalgia) • Patients with MRI-contraindications (e.g. instable metal implants, pacemaker/ICD, vascular clips, pregnancy).

Design outcomes

Primary

Measure	Time frame
Progression to clinical detectable arthritis and rheumatoid arthritis	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results